Search Results - "Jóhannesson, Vilberg"

Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer by Jóhannesson, Vilberg, Gunnlaugsson, Adalsteinn, Nilsson, Per, Brynolfsson, Patrik, Kjellén, Elisabeth, Wieslander, Elinore

“…•Evaluation of delivered dose in prostate salvage radiotherapy based on CBCT.•Deformable CT/CBCT registration evaluated with Dice coefficient showed robust…”
Get full text

Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule by Wieslander, Elinore, Jóhannesson, Vilberg, Nilsson, Per, Kjellén, Elisabeth, Gunnlaugsson, Adalsteinn

“…Ultrahypofractionated (UHF) radiation therapy (RT) has become a treatment alternative for patients with localized prostate cancer. In more advanced cases,…”
Get full text

ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children by Hoeben, Bianca A.W., Pazos, Montserrat, Seravalli, Enrica, Bosman, Mirjam E., Losert, Christoph, Albert, Michael H., Boterberg, Tom, Ospovat, Inna, Mico Milla, Soraya, Demiroz Abakay, Candan, Engellau, Jacob, Jóhannesson, Vilberg, Kos, Gregor, Supiot, Stéphane, Llagostera, Camille, Bierings, Marc, Scarzello, Giovanni, Seiersen, Klaus, Smith, Ed, Ocanto, Abrahams, Ferrer, Carlos, Bentzen, Søren M., Kobyzeva, Daria A., Loginova, Anna A., Janssens, Geert O.

“…•Toxicity reduction with outcome preservation is a goal of myeloablative TBI in children.•Fractionated TBI of 12–14.4 Gy, in 1.6–2 Gy fractions b.i.d. is…”
Get full text

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer by Jóhannesson, Vilberg, Wieslander, Elinore, Nilsson, Per, Brun, Eva, Bitzén, Ulrika, Ahlgren, Göran, Olsson, Tomas, Bäck, Sven, Kjellén, Elisabeth, Gunnlaugsson, Adalsteinn

“…Treatment adaptation based on tumour biomarker response during radiotherapy of prostate cancer, could be used for both escalation and de-escalation of…”
Get full text

A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial by Gunnlaugsson, Adalsteinn, Johannesson, Vilberg, Wieslander, Elinore, Brun, Eva, Bitzén, Ulrika, Ståhl, Olof, Bratt, Ola, Ahlgren, Göran, Ohlsson, Tomas, Kjellén, Elisabeth, Nilsson, Per

“…•PSA response during the first weeks of salvage radiotherapy (SRT) of prostate cancer is highly predictive for tumour control.•PSA responders received…”
Get full text

PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study by Gunnlaugsson, Adalsteinn, Kjellén, Elisabeth, Bratt, Ola, Ahlgren, Göran, Johannesson, Vilberg, Blom, René, Nilsson, Per

“…•Biochemical recurrence after prostatectomy is treated with salvage radiotherapy.•Several established pre-treatment factors predict outcome.•PSA decay rate…”
Get full text

A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68 Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial by Gunnlaugsson, Adalsteinn, Johannesson, Vilberg, Wieslander, Elinore, Brun, Eva, Bitzen, Ulrika, Ståhl, Olof, Bratt, Ola, Ahlgren, Göran, Ohlsson, Tomas, Kjellén, Elisabeth, Nilsson, Per

“…The treatment of biochemical recurrence (BCR) after prostatectomy is challenging as the site of the recurrence is often undetectable. Our aim was to test a…”
Get full text